Entry Point Capital, LLC Insulet Corp Transaction History
Entry Point Capital, LLC
- $112 Billion
- Q1 2024
A detailed history of Entry Point Capital, LLC transactions in Insulet Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 571 shares of PODD stock, worth $110,990. This represents 0.09% of its overall portfolio holdings.
Number of Shares
571Holding current value
$110,990% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding PODD
# of Institutions
628Shares Held
63MCall Options Held
339KPut Options Held
953K-
Vanguard Group Inc Valley Forge, PA8.2MShares$1.59 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.56MShares$1.47 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$1.17 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.92MShares$567 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA1.99MShares$387 Million0.06% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $13.5B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...